Impact of MFN Pricing on Medicare's Drug Spending for Obesity Treatments
Explore how MFN pricing for GLP-1RAs impacts Medicare spending and beneficiaries, while addressing obesity treatment affordability and regulatory challenges.
Medicare GLP-1 Bridge Program: A Paradigm Shift in Drug Pricing
Explore the CMS Medicare GLP-1 Bridge program revolutionizing drug pricing for Medicare beneficiaries with a fixed $50 monthly cost.
Impact of CMS Proposal on Drug Price Negotiations and Innovation
Explore the CMS proposal's impact on drug pricing negotiations, innovation, and pharmaceutical investment strategies in this crucial healthcare policy update.
New CMS Guidance on Medicare Drug Pricing Initiatives
Discover CMS's draft guidance on Medicare drug pricing, impacting stakeholders and beneficiaries, designed to streamline processes and enhance compliance.
Proposed Changes to Medicare Payment Systems for 2027
Explore the proposed 2027 Medicare payment system changes, affecting outpatient services, drug pricing, and quality reporting. Learn about key impacts for providers.
Phil Perry Retires: Impact on 340B Program Litigation and Regulation
Phil Perry's retirement signals notable changes in 340B litigation as CMS proposes a new rule impacting drug payments; public comment open through August 2026.
Rising Medicare Costs for HIV Treatment: Impacts and Solutions
Explore the projected rise of Medicare costs for HIV treatment and the potential strategies to manage these expenses effectively.
Trump Administration Proposes Medicare Drug Pricing Reform
The Trump administration proposes Medicare drug pricing reform aimed at reducing costs for patients and enhancing healthcare affordability. Read on for insights!
New Medicare Regulation Aims to Cut Drug Prices for Hospitals
The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.
New HHS Rule Seeks to Cut Drug Prices for Medicare Beneficiaries
The new HHS rule aims to cut drug prices for Medicare beneficiaries, targeting cost savings for hospitals in the 340B program while addressing billing concerns.